Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration

10.1002/jps.21860

Saved in:
Bibliographic Details
Main Authors: Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Humphreys, J.E., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S., Lou, Y.
Other Authors: PHARMACOLOGY
Format: Article
Published: 2011
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/27290
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-27290
record_format dspace
spelling sg-nus-scholar.10635-272902023-10-25T21:45:12Z Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration Adkison, K.K. Vaidya, S.S. Mehta, A.A. Lee, D.Y. Polli, J.W. Humphreys, J.E. Koo, S.H. Li, L. Lee, E.J.D. Gross, A.S. Lou, Y. PHARMACOLOGY ABC transporters Clinical pharmacokinetics Drug interactions Metabolite kinetics Pharmacogenetics 10.1002/jps.21860 Journal of Pharmaceutical Sciences 99 2 1046-1062 2011-09-29T05:54:45Z 2011-09-29T05:54:45Z 2010 Article Adkison, K.K., Vaidya, S.S., Mehta, A.A., Lee, D.Y., Polli, J.W., Humphreys, J.E., Koo, S.H., Li, L., Lee, E.J.D., Gross, A.S., Lou, Y. (2010). Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration. Journal of Pharmaceutical Sciences 99 (2) : 1046-1062. ScholarBank@NUS Repository. https://doi.org/10.1002/jps.21860 00223549 15206017 http://scholarbank.nus.edu.sg/handle/10635/27290 000274114100042 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic ABC transporters
Clinical pharmacokinetics
Drug interactions
Metabolite kinetics
Pharmacogenetics
spellingShingle ABC transporters
Clinical pharmacokinetics
Drug interactions
Metabolite kinetics
Pharmacogenetics
Adkison, K.K.
Vaidya, S.S.
Mehta, A.A.
Lee, D.Y.
Polli, J.W.
Humphreys, J.E.
Koo, S.H.
Li, L.
Lee, E.J.D.
Gross, A.S.
Lou, Y.
Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
description 10.1002/jps.21860
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Adkison, K.K.
Vaidya, S.S.
Mehta, A.A.
Lee, D.Y.
Polli, J.W.
Humphreys, J.E.
Koo, S.H.
Li, L.
Lee, E.J.D.
Gross, A.S.
Lou, Y.
format Article
author Adkison, K.K.
Vaidya, S.S.
Mehta, A.A.
Lee, D.Y.
Polli, J.W.
Humphreys, J.E.
Koo, S.H.
Li, L.
Lee, E.J.D.
Gross, A.S.
Lou, Y.
author_sort Adkison, K.K.
title Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
title_short Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
title_full Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
title_fullStr Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
title_full_unstemmed Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration
title_sort oral sulfasalazine as a clinical bcrp probe substrate: pharmacokinetic effects of genetic variation (c421a) and pantoprazole coadministration
publishDate 2011
url http://scholarbank.nus.edu.sg/handle/10635/27290
_version_ 1781410594828582912